Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

PLIANT THERAPEUTICS, INC. (PLRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 4 Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Sold 13,069 shares @ $20, valued at $261.4k
Sold 1,800 shares @ $20, valued at $36k
Sold 20,050 shares @ $20.01, valued at $401.2k
Exercised 1,800 options to buy @ $2.08, valued at $3.7k
Exercised 8,791 options to buy @ $2.08, valued at $18.3k
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 4 Ouimette Mike (General Counsel & Corp. Sec'y) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 27,187 shares @ $0
07/18/2023 4 Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 43,750 shares @ $0
07/18/2023 4 Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 35,156 shares @ $0
07/18/2023 4 Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 38,750 shares @ $0
07/18/2023 4 Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 137,500 shares @ $0
06/12/2023 4 Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Exercised 5,800 options to buy @ $2.08, valued at $12.1k
06/08/2023 4 Shah Smital (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/08/2023 4 PYOTT DAVID E I (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/08/2023 4 MCCOURT Thomas A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/08/2023 4 Knobil Katharine (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/08/2023 4 Huh Hoyoung (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/08/2023 4 Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/08/2023 4 CROWELL GAYLE A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/08/2023 4 Cline Darren S (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
06/08/2023 4 Bruhn Suzanne Louise (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 14,000 options to buy @ $23.09, valued at $323.3k
04/03/2023 4 Ouimette Mike (General Counsel & Corp. Sec'y) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Sold 4,874 shares @ $26.5209, valued at $129.3k
Sold 2,677 shares @ $26.7371, valued at $71.6k
Sold 200 shares @ $27.455, valued at $5.5k
04/03/2023 4 Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Sold 11,245 shares @ $26.5209, valued at $298.2k
04/03/2023 4 Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Sold 9,036 shares @ $26.5209, valued at $239.6k
04/03/2023 4 Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Sold 9,960 shares @ $26.5209, valued at $264.1k
04/03/2023 4 Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Sold 35,339 shares @ $26.5209, valued at $937.2k
03/31/2023 4 Ouimette Mike (General Counsel & Corp. Sec'y) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 13,593 shares @ $0
03/31/2023 4 Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 21,874 shares @ $0
03/31/2023 4 Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 17,578 shares @ $0
03/31/2023 4 Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 19,375 shares @ $0
03/31/2023 4 Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 68,749 shares @ $0
03/08/2023 4 MCCOURT Thomas A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.
Txns: Granted 22,000 options to buy @ $31.11, valued at $684.4k
03/08/2023 3 MCCOURT Thomas A (Director) has filed a Form 3 on PLIANT THERAPEUTICS, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy